| HOME >> MEDICINE >> TECHNOLOGY |
41,399Convertible notes
2,777,086
2,556,014
2,528,848
377,976Deferred income taxes
67,134
72,518
78,408
11,720Total liabilities
3,105,373
2,895,222
2,884,241
431,095Shareholders' equityOrdinary shares US$0.1 par value:
500,000,000 authorized; 322,680,001 issued and outstanding as of March 31, 2010, June 30, 2010 and September 30, 2010
258,840
258,840
258,840
38,688Additional paid-in capital
808,221
820,778
830,016
124,058Treasury stock
(45,143)
(47,108)
(47,108)
(7,041)Accumulated other comprehensive loss
(70,556)
(70,731)
(74,412)
(11,122)Retained earnings
852,334
886,012
883,076
131,990Total shareholders' equity
1,803,696
1,847,791
1,850,412
276,573Total liabilities and shareholders' equity
4,909,069
4,743,013
4,734,653
707,668China Medical Technologies, Inc.Unaudited Condensed Consolidated Statements of IncomeFor the Three Months EndedSeptember 30, 2009June 30, 2010September 30, 2010RMBRMBRMBUS$ As adjusted (4)(in thousands except for per ADS information)Revenues, net (1)
166,066
186,170
201,834
30,167Cost of revenues (2)
(57,517)
(61,354)
(90,477)
(13,523)Gross profit
108,549
124,816
111,357
16,644Operating expensesResearch and development (2)
(9,500)
(10,632)
(10,877)
(1,625)Sales and marketing (2)
(17,432)
(18,266)
(21,473)
(3,209)General and administrative (2)
(45,130)
(25,149)
(25,048)
(3,744) Amortization of SPR intangible assets
(27,357)
(27,329)
-
-Total operating expenses
(99,419)
(81,376)
| SOURCE China Medical Technologies, Inc. Copyright©2010 PR Newswire. All rights reserved |